Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione
- 1 August 1993
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 68 (2) , 393-398
- https://doi.org/10.1038/bjc.1993.347
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patientsEuropean Journal Of Cancer, 1992
- Clinical Pharmacokinetics of Endocrine Agents Used in Advanced Breast CancerClinical Pharmacokinetics, 1992
- Effects of aminoglutethimide on plasma estrone sulfate not caused by aromatase inhibitionJournal of Steroid Biochemistry, 1989
- Alterations in the urine excretion of estrogen metabolites in breast cancer women treated with aminoglutethimideThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- Mechanisms of Action of Aminoglutethimide as Endocrine Therapy of Breast CancerDrugs, 1988
- Alterations in the Metabolism of Oestrogens During Treatment with Aminoglutethimide in Breast Cancer PatientsClinical Pharmacokinetics, 1987
- The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS—I. Quantitation of estrogens after initial hydrolysis of conjugatesThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- Induction of microsomal cytochrome P-450 enzymes: The first Bernard B. Brodie lecture at Pennsylvania State UniversityLife Sciences, 1986
- Estrone sulfate: A potential source of estradiol in human breast cancer tissuesBreast Cancer Research and Treatment, 1986
- Hydrocortisone alone vs hydrocortisone plus aminogluthethimide: a comparison of the endocrine effects in postmenopausal breast cancerEuropean Journal of Cancer and Clinical Oncology, 1984